NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 34 / 982

  1. Gender differences in the association between housing status and violence among people who report exposure to benzodiazepines.2026 · PubMed
  2. Gender differences in the impact of psychological distress on methamphetamine use disorder outcomes and treatment effect2026 · Crossref
  3. Gender disparities in patterns and outcomes of substance use disorder among psychiatric inpatients in Southeastern Nigeria: A retrospective study.2026 · PubMed
  4. Gender Disparities in Suicide Fatalities Due to Recreational Drug Poisoning: A National Analysis from 2018 to 20232026 · Crossref
  5. Gender Diversity, Substance Cognitions, and Alcohol, Nicotine/Tobacco, and Cannabis Use Among Youth2026 · Crossref
  6. Gender identity and cannabis use in Canada and the United States: cross-sectional analysis of the International Cannabis Policy Study2026 · Crossref
  7. Gender-Specific Associations Between Tobacco and Tobacco-Free Nicotine Use and Symptoms of Anxiety and Depression in Swedish Adolescents2026 · Crossref
  8. Gendered Differences in the Effects of Adverse Childhood Experiences on Adolescent Substance Use2026 · Crossref
  9. Gendered Dimensions of Social Support in Therapeutic Communities: A Qualitative Study on Recovery Pathways Among Individuals with Substance Use Disorders in Brazil2026 · Crossref
  10. Gendering The Opium Economy: Women’s Labour and Agrarian Extraction in Colonial Bihar 1770-19102026 · Crossref
  11. General Assessment of Indole Derivatives and Wnt Pathway as Potential Key Factors Against Various Diseases, with Particular Emphasis on Thyroid Tumors.2026 · PubMed
  12. Genetic Advances in Cannabis sativa L.: A Review of Recent Progress and Future Directions2026 · Crossref
  13. Genetic architecture of phenological, morphological, and phytochemical traits in Cannabis landraces.2026 · PubMed
  14. Genetic Basis of Tobacco Use Disorder2026 · Crossref
  15. Genetic nurture in intergenerational transmission of substance use2026 · Crossref
  16. Genetic overlap of chronic pain, musculoskeletal‐specific pain, substance use disorders and substance use consumption: Common addiction and substance‐specific effects2026 · Crossref
  17. Genetic pleiotropy differentially linking brain variation to cannabis use and cannabis use disorder2026 · Crossref
  18. Genetic risk for schizophrenia modulates WIN 55,212-2 reward: Evidence from a heterozygous transmembrane domain neuregulin 1 mutant mouse model2026 · Crossref
  19. Genetic susceptibility and gene-environment interactions in gastric cancer among ethnic populations of Northeast India.2026 · PubMed
  20. Genetic variation in cerebellar nicotinic acetylcholine receptor (nAChR) function impacts efficacy of nicotine and varenicline treatment of alcohol withdrawal-induced motor impairment.2026 · PubMed
  21. Genome editing-CRISPR/Cas9 for the crop improvement of Industrial Cannabis sativa (Hemp)2026 · OpenAlex
  22. Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases.2026 · PubMed
  23. Genome-Resolved Delineation of Three Novel Endophytic Achromobacter Species from Desert Medicinal Plants2026 · Crossref
  24. Genome-Resolved insights into significance of DNRA Microbes in N<sub>2</sub>O production during manure composting.2026 · PubMed
  25. Genome-Resolved Metagenomics Revealed the Functional Potential of Core Novel and Known Genera Key to Processes in Full-Scale Aerobic Granular Sludge Plants.2026 · PubMed
  26. GENOME-WIDE ANALYSIS AND IDENTIFICATION OF HSF (HEAT SHOCK TRANSCRIPTION FACTOR) GENES IN COFFEE (COFFEE ARABICA L.) UNDER ABIOTIC STRESS2026 · Crossref
  27. Genome-Wide Identification of the R2R3-MYB Gene Family Members in Masson Pine and the Regulation of Secondary Cell Wall Formation and Lignin Biosynthesis by PmMYB2892026 · Crossref
  28. Genome-Wide Identification, Phylogenetic Analysis and Salt-Responsive Expression Profiling of the MYB Transcription Factor Family in Cannabis sativa L. During Seed Germination2026 · Crossref
  29. Genomic elucidation of hybridization between Liberica and excelsa coffee and its implications for coffee crop development2026 · Crossref
  30. Genotoxic Potential of Metodesnitazene and Etodesnitazene: Insights with and Without S9 Metabolic Activation.2026 · PubMed
  31. Genotoxicity risk assessment of a 7-hydroxymitragynine-enriched Kratom preparation: An integrated in silico and in vitro approach.2026 · PubMed
  32. Genotype-dependent In Vitro Floral Induction and Reversion in Moroccan Cannabis sativa L. Varieties under Zeatin, Gibberellic Acid, and Thidiazuron Treatments2026 · Crossref
  33. Geographic Variations of Intensive Care Unit Admissions with Substance-Related Diagnoses in the United States.2026 · PubMed
  34. Getting Back to Basics: How the Sentencing Commission’s Proposed and Adopted 2025 Amendments to the Drug and Supervised Release Guidelines Better Align the Guidelines with Their Stated Purposes2026 · Crossref
  35. GH001 Efficacy is Independent of Prior Antidepressant Treatment Failures in Treatment-Resistant Depression: A Post Hoc Analysis of a Phase 2b Randomized Controlled Trial.2026 · PubMed
  36. GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.2026 · PubMed
  37. Giant bladder calculus presenting as a rare cause of renal impairment in a young adult with substance use disorder2026 · Crossref
  38. Gibberellin pathway remodeling accompanies ethylene-driven sex reversal in Cannabis sativa2026 · Crossref
  39. Gingivobuccal Cancers: Demographics and Geographic Variations.2026 · PubMed
  40. Give Strong Drink to Him Who Is Perishing”: Rhetoric, Royal Responsibility, and the Ethics of Sobriety in Proverbs 31:6–72026 · Crossref
  41. GIÁ TRỊ VĂN HÓA BẢN ĐỊA TRONG PHÁT TRIỂN CHUỖI GIÁ TRỊ CÀ PHÊ BỀN VỮNG TẠI TÂY NGUYÊN2026 · Crossref
  42. Glibenclamide exerts region-specific modulatory effects on monoaminergic neurotransmission and partially restores memory consolidation in a scopolamine-induced model of cognitive impairment.2026 · PubMed
  43. Global analysis of regulatory definitions of tobacco and nicotine-containing products2026 · Crossref
  44. Global burden of esophageal cancer attributable to smoking and alcohol, 1990-2021, with projections to 2040: a population-based analysis of the global burden of disease study 2021.2026 · PubMed
  45. Global emergence and γ-aminobutyric acid type A (GABA<sub>A</sub>) receptor activity of the new designer benzodiazepine ethylbromazolam.2026 · PubMed
  46. Global expansion of China National Tobacco Corporation and its implications for international tobacco control2026 · Crossref
  47. Global Heated Tobacco Product User Estimates, 2014-2024: Descriptive Surveillance Study Using Manufacturer Disclosures2026 · Crossref
  48. Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [<sup>18</sup>F]FDG-PET study.2026 · PubMed
  49. Global Lip and Oral Cavity Cancer: Analysis of the 2021 Global Burden of Disease Study.2026 · PubMed
  50. Global narcotics regulations: An overview of international drug control conventions and the need for responsible legal regulation2026 · Crossref
  51. Global patterns of commodity-driven deforestation and associated carbon emissions2026 · Crossref
  52. Global Perspectives on CNS Drug Innovation: Achievements, Barriers, and Priorities for the Next Decade.2026 · PubMed
  53. Global perspectives on treatment and harm reduction services for opioid use disorder: Results from an international survey.2026 · PubMed
  54. Global prevalence and disability burden of brain disorders: Impact of neurological, mental, and substance use disorders.2026 · PubMed
  55. Global prevalence of kratom use: a meta-analysis focusing on regional and population-level disparities.2026 · PubMed
  56. Global research on tobacco taxation and pricing policies: trends, themes and collaboration: a bibliometric analysis2026 · Crossref
  57. Global Research Trends in Community-Based Strategies for Reducing Risky Alcohol Consumption and Promoting Health2026 · Crossref
  58. Global substance use disorders burden from 1990 to 2021: post-COVID shifts and widening inequalities.2026 · PubMed
  59. Global Trends in Synthetic Drug Use and Their Criminological Prevention2026 · Crossref
  60. Global trends of menthol cigarette use among people who smoke in 25 countries of the International Tobacco Control Project, 2005-20232026 · Crossref
  61. GLP ‐1 Receptor Agonists for Treating Alcohol Use Disorder: A Critical Review2026 · Crossref
  62. GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation.2026 · PubMed
  63. GLP-1 RAs in Substance Use Disorders: Emerging Evidence and Future Directions2026 · Crossref
  64. GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and Diabetes.2026 · PubMed
  65. GLP-1 receptor agonists at the crossroads of obesity and addiction: A review of shared neurobiology and translational evidence.2026 · PubMed
  66. GLP-1 Receptor Agonists Beyond Glycemic Control: Clinical Implications in Neurodegenerative Disease and Substance Use Disorders2026 · Crossref
  67. Glucagon-like Peptide-1 Receptor Agonists and Their Potential Role in the Treatment of Substance Use Disorders: A Narrative Review2026 · Crossref
  68. Glucagon-like Peptide-1 Receptor Agonists for Substance Use Disorders: Comprehensive Review of Circuit Mechanisms and Clinical Evidence2026 · Crossref
  69. Glucagon‐like peptide‐1 receptor agonist use and violent crime among US adults2026 · Crossref
  70. Glucagon‐Like Peptide‐1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms2026 · Crossref
  71. Glucosamine/chitosan blend surface-engineered rutin-loaded polymer/lipid hybrid nanoparticles for neuroprotection in induced schizophrenia model.2026 · PubMed
  72. Glutamatergic Dysregulation in Depression, Schizophrenia, and Addiction: Mechanisms and Therapeutic Strategies2026 · OpenAlex
  73. Glutathione as a Potential Neuroprotectant Against MDMA-Induced Oxidative Stress, Neuroinflammation, and Apoptosis in the Rat Brain.2026 · PubMed
  74. Gluteal compartment syndrome following prolonged immobilization in the setting of polysubstance use: A two-patient case series.2026 · PubMed
  75. GlyT1 inhibition enhances working memory in the mouse TUNL task and normalizes NMDA antagonist-induced network activity.2026 · PubMed
  76. Gobernanza colonial de la minera Las Bambas y consecuencias sobre el conflicto socioambiental2026 · Crossref
  77. Governance and Drug Prices: An Empirical Analysis Within the European Monetary Union2026 · Crossref
  78. Governing at a distance: how digital–physical hybridity reshapes drug markets and risk in Scotland2026 · Crossref
  79. Governing Urban Wetlands for Decarbonization: Integrating Policy, Infrastructure, and Biogeochemistry.2026 · PubMed
  80. GPCR heteromers: Beyond the monomeric paradigm in neuropsychiatric drug discovery.2026 · PubMed
  81. Grandparent Prenatal Tobacco, Alcohol, Coffee, and Tea Consumption and Autism in the Third Generation2026 · Crossref
  82. Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder.2026 · PubMed
  83. Green Consciousness dalam Meningkatkan Emotional Attachment dan Customer Loyalty Coffee Shop2026 · Crossref
  84. Green Purification of Mitragynine from Kratom Leaves (Mitragyna speciosa) through Solvent Variation in Acid-Base Extraction2026 · Crossref
  85. Green Synthesis of CeO 2 Nanoparticles Using Cannabis sativa L. Seed Extract for Antibacterial and Breast Cancer Applications2026 · Crossref
  86. Greenhouse gas emissions in natural and degraded tropical peatlands.2026 · PubMed
  87. Grief and Substance Use: A Thematic Synthesis of Qualitative Research2026 · Crossref
  88. Group psychedelic-assisted therapy for mental health conditions: a mixed-methods systematic review2026 · Crossref
  89. Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.2026 · PubMed
  90. Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study2026 · Crossref
  91. Growth and biomass response of industrial hemp ( Cannabis sativa L.) cultivars to nitrogen rates for fiber production2026 · Crossref
  92. GSDMD-mediated pyroptosis in the dorsal hippocampus is implicated in morphine-induced reward memory in mice.2026 · PubMed
  93. Gut <i>Proteobacteria</i> glycine metabolism regulates neuroplasticity, motivation, and reinstatement of cocaine self-administration in mice.2026 · PubMed
  94. Gut-immune-PVAT axis is involved in ethanol-induced abdominal aortic dysfunction via IL-17RA, TLR4, and FPR1 signaling.2026 · PubMed
  95. GZ21T as an emerging topical dermatologic therapy: A literature review.2026 · PubMed
  96. Habitual checking, delayed tasks: Why parental mediation fails to moderate adolescent mobile habits and procrastination2026 · Crossref
  97. Hair neuroendocrine signatures of acute stress reaction symptoms: Cross-national validation and latent profile heterogeneity.2026 · PubMed
  98. Hallucinations Induced by Psychoactive Drugs: Mechanisms, Consequences, and Therapeutic Interventions2026 · OpenAlex
  99. Hallucinogen Persisting Perception Disorder in a Young Adult Case Report2026 · OpenAlex
  100. Hallucinogen use in the United States, 2021-2023: Diverging trends and subgroup patterns.2026 · PubMed